Gag Protein Oriented Supramolecular Nets as Potential HIV Traps.

Area of Science:

• Biochemistry
• Nanotechnology
• Virology

Background:

• Current HIV/AIDS treatment relies on combination antiretroviral therapy, but faces challenges like drug toxicity, patient adherence, and resistance.
• Developing novel strategies is crucial to overcome the limitations of existing HIV therapies.

Purpose of the Study:

• To design and investigate a novel HIV Gag protein-targeting redox supramolecular assembly (ROSA) system for potential HIV inhibition.
• To explore a new anti-HIV strategy based on self-assembling nanomaterials.

Main Methods:

• Conjugation of an oxidation-activatable fluorogenic compound (BQA) with a tetrapeptide (GGFF) to create an assembling precursor.
• Investigating the precursor's binding affinity to HIV Gag protein.
• Evaluating the virus-trapping capability of the oxidized nanofibers.

Main Results:

• The precursor demonstrated moderate affinity for HIV Gag protein due to structural similarities with known inhibitors.
• Oxidized ROSA nanofibers effectively bound to Gag protein and trapped HIV particles.
• The ROSA system showed potential for controlling HIV replication.

Conclusions:

• The ROSA system presents a promising new strategy for HIV inhibition by targeting the Gag protein.
• This approach offers a potential alternative to conventional antiretroviral therapies, addressing issues of toxicity and resistance.